Stryker acquires 95.5% of Vexim, plans squeeze-out

Stryker acquired approximately 95.5% of the share capital of French spinal implant maker Vexim and plans a public buy-out offer and squeeze-out for the remaining shares at about $24.88 per share, expected in Q2 2018.

“Stryker said it has acquired approximately 95.5% of the share capital of French spinal implant maker Vexim, and that it plans to acquire the remaining shares soon.”massdevice.com

• 1 source
• massdevice.comStryker nears closure of Vexim takeover, passes 95% ownership - MassDeviceFink DensfordFeb 14, 2018

Summarized from public sources; check the original articles before acting on it.